Guardant Health, Inc. GH NASDAQ

Guardant Health, Inc. (GH) generated $-184.76M in operating cash flow for fiscal year 2025. After capital expenditures of $48.31M, free cash flow was $-233.07M.

Free cash flow margin was -23.7% of revenue. Cash conversion ratio was 0.44x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (72/100, Pass) — $-233.07M (-23.7% FCF margin) supports a durable competitive advantage
• INCOME (10/100) — Cash conversion ratio was 0.44x suggests some earnings are non-cash items

Overall SharesGrow Score: 57/100 with 4/7 criteria passed.